OMB
.report
Search
Phase 1 - Main Study Completes (Consumers)
Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials
OMB: 0910-0902
IC ID: 249298
OMB.report
HHS/FDA
OMB 0910-0902
ICR 202109-0910-005
IC 249298
( )
Documents and Forms
Document Name
Document Type
Appendix A - Informed Consent.docx
Other-Informed Consent
Appendix A - Informed Consent.docx
Other-Informed Consent
Appendix B - Study 1 and 2 Questionnaires.docx
Other-Questionnaires
Appendix B - Study 1 and 2 Questionnaires.docx
Other-Questionnaires
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Phase 1 - Main Study Completes (Consumers)
Agency IC Tracking Number:
CDER
Is this a Common Form?
No
IC Status:
New
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-Informed Consent
Appendix A - Informed Consent.docx
Yes
Yes
Fillable Fileable
Other-Questionnaires
Appendix B - Study 1 and 2 Questionnaires.docx
Yes
Yes
Fillable Fileable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Consumer Health and Safety
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
495
Number of Respondents for Small Entity:
0
Affected Public:
Individuals or Households
Percentage of Respondents Reporting Electronically:
100 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
495
0
495
0
0
0
Annual IC Time Burden (Hours)
163
0
163
0
0
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
No associated records found
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.